jan 1, 2003 - First targeted drugs for lung cancer attack "EGFR" receptor

Description:

FDA approves two new targeted treatments for lung cancer, gefitinib and erlotinib.

Added to timeline:

16 Nov 2018

0

0

252

Cancer Dates

Date: